HEREDITARY ANGIOEDEMA - TYPE 1
Clinical trials for HEREDITARY ANGIOEDEMA - TYPE 1 explained in plain language.
Never miss a new study
Get alerted when new HEREDITARY ANGIOEDEMA - TYPE 1 trials appear
Sign up with your email to follow new studies for HEREDITARY ANGIOEDEMA - TYPE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Silencing the gene: new trial aims to stop debilitating swelling attacks
Disease control Recruiting nowThis study is testing a new drug called ADX-324 to see if it can prevent the sudden, painful swelling attacks caused by hereditary angioedema (HAE). It will involve about 90 adults with HAE who will receive either the drug or a placebo. The main goal is to see if the drug reduces…
Matched conditions: HEREDITARY ANGIOEDEMA - TYPE 1
Phase: PHASE3 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Smartphone study tracks hidden daily struggle of rare swelling disorder
Knowledge-focused Recruiting nowThis study aims to better understand how hereditary angioedema affects patients' daily lives by tracking their experiences in real time. Over 8 weeks, 30 adult participants will use their smartphones to answer brief daily surveys about their mood, stress, and how the disease impa…
Matched conditions: HEREDITARY ANGIOEDEMA - TYPE 1
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Knowledge-focused
Last updated Apr 01, 2026 23:26 UTC